KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Interest Expenses (2017 - 2025)

Historic Interest Expenses for Arbutus Biopharma (ABUS) over the last 9 years, with Q3 2025 value amounting to $23000.0.

  • Arbutus Biopharma's Interest Expenses fell 2068.97% to $23000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $109000.0, marking a year-over-year decrease of 2781.46%. This contributed to the annual value of $137000.0 for FY2024, which is 7015.25% down from last year.
  • As of Q3 2025, Arbutus Biopharma's Interest Expenses stood at $23000.0, which was down 2068.97% from $28000.0 recorded in Q2 2025.
  • Arbutus Biopharma's 5-year Interest Expenses high stood at $772000.0 for Q1 2021, and its period low was $23000.0 during Q3 2025.
  • Over the past 5 years, Arbutus Biopharma's median Interest Expenses value was $171000.0 (recorded in 2023), while the average stood at $276736.8.
  • Per our database at Business Quant, Arbutus Biopharma's Interest Expenses plummeted by 8927.74% in 2023 and then crashed by 1764.71% in 2025.
  • Arbutus Biopharma's Interest Expenses (Quarter) stood at $560000.0 in 2021, then tumbled by 44.82% to $309000.0 in 2022, then tumbled by 85.76% to $44000.0 in 2023, then plummeted by 31.82% to $30000.0 in 2024, then fell by 23.33% to $23000.0 in 2025.
  • Its last three reported values are $23000.0 in Q3 2025, $28000.0 for Q2 2025, and $28000.0 during Q1 2025.